Biotech Co. Says Rival Stole Trade Secrets In 'Brazen Fraud'
A recently launched Massachusetts biotech startup stole detailed lung cancer drug research from a Dana-Farber Cancer Institute-linked firm amid due diligence discussions through bad-faith dealings and "brazen fraud," according to a...To view the full article, register now.
Already a subscriber? Click here to view full article